Table 1.
Summary of patient characteristics
| Number | Age at diagnosis | |
|---|---|---|
| Sample set 1 | ||
| Benign serous cystadenoma | 11 | 57 years (28–88) |
| Borderline tumor | 9 | 49 years (31–61) |
| Serous ovarian cancer | 46 | 63 years (27–86) |
| Stage | ||
| 1 | 11 | |
| 2 | 12 | |
| 3 | 14 | |
| 4 | 9 | |
| Grade | ||
| 1 | 3 | |
| 2 | 5 | |
| 3 | 37 | |
| n.d. | 2 | |
| Overall survival | 48.6 months (4.4–226.7) | |
| Sample set 2 | ||
| Primary and patient-matched metastatic cancer | 23 | 66 years (49–87) |
| Stage | ||
| 3 | 23 | |
| Grade | ||
| 1 | 1 | |
| 2 | 4 | |
| 3 | 18 | |
| Overall survival | 23.9 months (0.10–58.3) | |
n.d. not determined